Pulmonary Manifestations of Systemic Lupus Erythematosus

Clinics in Chest Medicine

Volumn 31, Issue 3, 2010, Pages 479-488

  Kamen, Diane L ^a   Strange, Charlie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Inflammation; Lung disease; Lupus; Pulmonary

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BOSENTAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEPARIN; MEPREDNISONE; METHOTREXATE; MYCOPHENOLIC ACID; PLACEBO; PREDNISONE; PROSTACYCLIN; RITUXIMAB; THEOPHYLLINE; VASODILATOR AGENT; WARFARIN;

ACUTE LUPUS PNEUMONITIS; ADULT RESPIRATORY DISTRESS SYNDROME; CAUSAL ATTRIBUTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRACKLE; DNA POLYMORPHISM; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED DISEASE; DRUG MEGADOSE; DYSPNEA; EPIDEMIOLOGICAL DATA; GENETIC SUSCEPTIBILITY; HUMAN; HYPOXEMIA; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG HEMORRHAGE; LUNG TOXICITY; PLEURA DISEASE; PLEURA EFFUSION; PLEURISY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SHRINKING LUNG SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77955345470     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.05.001     Document Type: Review

References (86)

1. Pisetsky D.S., Gilkeson G., St Clair E.W. Systemic lupus erythematosus. Diagnosis and treatment. Med Clin North Am 1997, 81:113-128.
2. Alarcon G.S., Friedman A.W., Straaton K.V., et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus 1999, 8:197-209.
3. Bernatsky S., Boivin J.F., Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006, 54:2550-2557.
4. Orens J.B., Martinez F.J., Lynch J.P. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994, 20:159-193.
5. Quadrelli S.A., Alvarez C., Arce S.C., et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 2009, 18:1053-1060.
6. Pego-Reigosa J.M., Medeiros D.A., Isenberg D.A. Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin Rheumatol 2009, 23:469-480.
7. Tsao B.P. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004, 16:513-521.
8. Pullmann R., Bonilla E., Phillips P.E., et al. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum 2008, 58:532-540.
9. Kremer Hovinga I.C., Koopmans M., Baelde H.J., et al. Tissue chimerism in systemic lupus erythematosus is related to injury. Ann Rheum Dis 2007, 66:1568-1573.
10. Good J.T., King T.E., Antony V.B., et al. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983, 84:714-718.
11. Pines A., Kaplinsky N., Olchovsky D., et al. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985, 88:129-135.
12. Winslow W.A., Ploss L.N., Loitman B. Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis. Ann Intern Med 1958, 49:70-88.
13. Bouros D., Pneumatikos I., Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008, 75:361-371.
14. Hunder G.G., McDuffie F.C., Hepper N.G. Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med 1972, 76:357-363.
15. Small P., Frank H., Kreisman H., et al. An immunological evaluation of pleural effusions in systemic lupus erythematosus. Ann Allergy 1982, 49:101-103.
16. Gilleece M.H., Evans C.C., Bucknall R.C. Steroid resistant pleural effusion in systemic lupus erythematosus treated with tetracycline pleurodesis. Ann Rheum Dis 1988, 47:1031-1032.
17. McKnight K.M., Adair N.E., Agudelo C.A. Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus. Arthritis Rheum 1991, 34:1483-1484.
18. Kaine J.L. Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage. Ann Rheum Dis 1985, 44:61-64.
19. Wiedemann H.P., Matthay R.A. Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imaging 1992, 7:1-18.
20. Cheema G.S., Quismorio F.P. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000, 6:424-429.
21. Witt C., Dorner T., Hiepe F., et al. Diagnosis of alveolitis in interstitial lung manifestation in connective tissue diseases: importance of late inspiratory crackles, 67 gallium scan and bronchoalveolar lavage. Lupus 1996, 5:606-612.
22. Matthay R.A., Schwarz M.I., Petty T.L., et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975, 54:397-409.
23. Leikin J.B., Arof H.M., Pearlman L.M. Acute lupus pneumonitis in the postpartum period: a case history and review of the literature. Obstet Gynecol 1986, 68:29S-31S.
24. Wiedemann H.P., Matthay R.A. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989, 10:677-722.
25. Lim S.W., Gillis D., Smith W., et al. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports. Intern Med J 2006, 36:260-262.
26. Weinrib L., Sharma O.P., Quismorio F.P. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990, 20:48-56.
27. Haupt H.M., Moore G.W., Hutchins G.M. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981, 71:791-798.
28. Boulware D.W., Hedgpeth M.T. Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol 1989, 16:479-481.
29. Tansey D., Wells A.U., Colby T.V., et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004, 44:585-596.
30. Karim M.Y., Miranda L.C., Tench C.M., et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002, 31:289-298.
31. Warrington K.J., Moder K.G., Brutinel W.M. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000, 75:467-472.
32. Toya S.P., Tzelepis G.E. Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review. Semin Arthritis Rheum 2009, 39:30-37.
33. Rubin L.A., Urowitz M.B. Shrinking lung syndrome in SLE-a clinical pathologic study. J Rheumatol 1983, 10:973-976.
34. Hardy K., Herry I., Attali V., et al. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001, 119:1274-1277.
35. Laroche C.M., Mulvey D.A., Hawkins P.N., et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989, 71:429-439.
36. Hawkins P., Davison A.G., Dasgupta B., et al. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001, 56:329-330.
37. Martens J., Demedts M., Vanmeenen M.T., et al. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983, 84:170-175.
38. Walz-Leblanc B.A., Urowitz M.B., Gladman D.D., et al. The " shrinking lungs syndrome" in systemic lupus erythematosus-improvement with corticosteroid therapy. J Rheumatol 1992, 19:1970-1972.
39. Soubrier M., Dubost J.J., Piette J.C., et al. Shrinking lung syndrome in systemic lupus erythematosus. A report of three cases. Rev Rhum Engl Ed 1995, 62:395-398.
40. Benham H., Garske L., Vecchio P., et al. Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J Clin Rheumatol 2010, 16:68-70.
41. Van Veen S., Peeters A.J., Sterk P.J., et al. The " shrinking lung syndrome" in SLE, treatment with theophylline. Clin Rheumatol 1993, 12:462-465.
42. Eagen J.W., Memoli V.A., Roberts J.L., et al. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978, 57:545-560.
43. Zamora M.R., Warner M.L., Tuder R., et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997, 76:192-202.
44. Badsha H., Teh C.L., Kong K.O., et al. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004, 33:414-421.
45. Hsu B.Y., Edwards D.K., Trambert M.A. Pulmonary hemorrhage complicating systemic lupus erythematosus: role of MR imaging in diagnosis. AJR Am J Roentgenol 1992, 158:519-520.
46. Strange C., Highland K.B. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004, 25:549-559. vii.
47. Myers J.L., Katzenstein A.A. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986, 85:552-556.
48. Schwab E.P., Schumacher H.R., Freundlich B., et al. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993, 23:8-15.
49. Abud-Mendoza C., Diaz-Jouanen E., Alarcon-Segovia D. Fatal pulmonary hemorrhage in systemic lupus erythematosus. Occurrence without hemoptysis. J Rheumatol 1985, 12:558-561.
50. Erickson R.W., Franklin W.A., Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 1994, 24:114-123.
51. Kim W.U., Kim S.I., Yoo W.H., et al. Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 1999, 8:552-557.
52. Andonopoulos A.P. Adult respiratory distress syndrome: an unrecognized premortem event in systemic lupus erythematosus. Br J Rheumatol 1991, 30:346-348.
53. Winslow T.M., Ossipov M.A., Fazio G.P., et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995, 129:510-515.
54. Simonson J.S., Schiller N.B., Petri M., et al. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989, 16:918-925.
55. Johnson S.R., Gladman D.D., Urowitz M.B., et al. Pulmonary hypertension in systemic lupus. Lupus 2004, 13:506-509.
56. Quismorio F.P., Sharma O., Koss M., et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984, 13:349-359.
57. Prabu A., Patel K., Yee C.S., et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 2009, 48:1506-1511.
58. Winslow T.M., Ossipov M., Redberg R.F., et al. Exercise capacity and hemodynamics in systemic lupus erythematosus: a Doppler echocardiographic exercise study. Am Heart J 1993, 126:410-414.
59. Asherson R.A., Mackworth-Young C.G., Boey M.L., et al. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) 1983, 287:1024-1025.
60. Boumpas D.T., Austin H.A., Fessler B.J., et al. Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995, 122:940-950.
61. Robbins I.M., Gaine S.P., Schilz R., et al. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest 2000, 117:14-18.
62. Asherson R.A., Higenbottam T.W., Dinh Xuan A.T., et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990, 17:1292-1298.
63. Hodson P., Klemp P., Meyers O.L. Pulmonary hypertension in systemic lupus erythematosus: a report of four cases. Clin Exp Rheumatol 1983, 1:241-245.
64. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus-do we need to know about it?. Lupus 2008, 17:274-277.
65. Minai O. An update in pulmonary hypertension in systemic lupus erythematosus-do we need to know about it?. Lupus 2009, 18:92.
66. Steen V., Chou M., Shanmugam V., et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008, 134:146-151.
67. Asherson R.A., Oakley C.M. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol 1986, 13:1-5.
68. Kasparian A., Floros A., Gialafos E., et al. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 2007, 16:505-508.
69. Rubin L.J., Badesch D.B., Barst R.J., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002, 346:896-903.
70. Gonzalez-Lopez L., Cardona-Munoz E.G., Celis A., et al. Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Lupus 2004, 13:105-112.
71. Jais X., Launay D., Yaici A., et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008, 58:521-531.
72. Levy R.D., Guerraty A.J., Yacoub M.H., et al. Prolonged survival after heart-lung transplantation in systemic lupus erythematosus. Chest 1993, 104:1903-1905.
73. Hutter J.A., Despins P., Higenbottam T., et al. Heart-lung transplantation: better use of resources. Am J Med 1988, 85:4-11.
74. Chung S.M., Lee C.K., Lee E.Y., et al. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 2006, 25:866-872.
75. Greenstone M.A. Delayed diagnosis of systemic lupus erythematosus associated pulmonary hypertension. Br J Rheumatol 1991, 30:391.
76. Ray J., Sermer M. Systemic lupus erythematosus and pulmonary hypertension during pregnancy: report of a case fatality. Can J Cardiol 1996, 12:753-756.
77. Abramson S.B., Dobro J., Eberle M.A., et al. Acute reversible hypoxemia in systemic lupus erythematosus. Ann Intern Med 1991, 114:941-947.
78. Martinez-Taboada V.M., Blanco R., Armona J., et al. Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?. Lupus 1995, 4:259-262.
79. Belmont H.M., Buyon J., Giorno R., et al. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994, 37:376-383.
80. Teitel A.D., MacKenzie C.R., Stern R., et al. Laryngeal involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1992, 22:203-214.
81. Langford C.A., Van Waes C. Upper airway obstruction in the rheumatic diseases. Rheum Dis Clin North Am 1997, 23:345-363.
82. Fenlon H.M., Doran M., Sant S.M., et al. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996, 166:301-307.
83. Keane M.P., Lynch J.P. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000, 55:159-166.
84. Kinder B.W., Freemer M.M., King T.E., et al. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum 2007, 56:2679-2686.
85. Lateef O., Shakoor N., Balk R.A. Methotrexate pulmonary toxicity. Expert Opin Drug Saf 2005, 4:723-730.
86. Abunasser J., Forouhar F.A., Metersky M.L. Etanercept-induced lupus erythematosus presenting as a unilateral pleural effusion. Chest 2008, 134:850-853.